Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Increased Ki-67 immunoreactivity in the white matter in hemimegalencephaly.

Munakata M, Watanabe M, Otsuki T, Itoh M, Uematsu M, Saito Y, Honda R, Kure S.

Neurosci Lett. 2013 Aug 26;548:244-8. doi: 10.1016/j.neulet.2013.05.033. Epub 2013 May 27.

PMID:
23721782
2.

Activation of microglia/macrophages expressing phosphorylated S6 ribosomal protein in a case of hemimegalencephaly with progressive calcification and atrophy.

Nonoda Y, Saito Y, Itoh M, Nakagawa E, Sugai K, Takahashi A, Otsuki T, Saito Y, Arima K, Mizuguchi M, Goto Y, Sasaki M.

J Neurol Sci. 2009 Dec 15;287(1-2):52-9. doi: 10.1016/j.jns.2009.09.010. Epub 2009 Oct 4.

PMID:
19804889
3.

Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.

Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, van Rijen PC, Jansen FE, Gorter JA, Reijneveld JC, Aronica E.

Epilepsia. 2009 Jun;50(6):1409-18. doi: 10.1111/j.1528-1167.2008.01955.x. Epub 2009 Feb 12.

4.

Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.

Arai A, Saito T, Hanai S, Sukigara S, Nabatame S, Otsuki T, Nakagawa E, Takahashi A, Kaneko Y, Kaido T, Saito Y, Sugai K, Sasaki M, Goto Y, Itoh M.

Brain Res. 2012 Aug 27;1470:89-97. doi: 10.1016/j.brainres.2012.06.009. Epub 2012 Jul 1.

PMID:
22759905
5.
6.

Diffusion-weighted imaging in fetuses with unilateral cortical malformations and callosal agenesis.

Glenn OA, Quiroz EM, Berman JI, Studholme C, Xu D.

AJNR Am J Neuroradiol. 2010 Jun;31(6):1100-2. doi: 10.3174/ajnr.A1863. Epub 2009 Nov 26.

7.

Postnatal evolution of cortical malformation in the "non-affected" hemisphere of hemimegalencephaly.

Kometani H, Sugai K, Saito Y, Nakagawa E, Sakuma H, Komaki H, Sasaki M, Adachi Y, Kaneko Y, Otsuki T, Hamano S.

Brain Dev. 2010 May;32(5):412-6. doi: 10.1016/j.braindev.2009.03.003. Epub 2009 Apr 2.

PMID:
19345027
8.

Expression patterns of AMOG in developing human cortex and malformations of cortical development.

Boer K, Spliet WG, van Rijen PC, Jansen FE, Aronica E.

Epilepsy Res. 2010 Sep;91(1):84-93. doi: 10.1016/j.eplepsyres.2010.06.015. Epub 2010 Jul 24.

PMID:
20656459
9.

Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.

Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.

J Mol Neurosci. 2013 May;50(1):7-13. doi: 10.1007/s12031-012-9841-2. Epub 2012 Jul 3.

PMID:
22752548
10.

Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.

Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, Aronica E.

Brain. 2011 Apr;134(Pt 4):1015-32. doi: 10.1093/brain/awr032. Epub 2011 Mar 16.

PMID:
21414994
11.

A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities.

Mathern GW, Andres M, Salamon N, Chandra PS, Andre VM, Cepeda C, Levine MS, Leite JP, Neder L, Vinters HV.

Epilepsia. 2007;48 Suppl 5:74-8. Erratum in: Epilepsia. 2007 Dec;48(12):2380.

12.

Ki-67 immunoreactivity in type II malformations of cortical development.

Prayson RA.

Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):357-61. doi: 10.1097/PAI.0b013e31812eef07.

PMID:
18528281
13.

Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.

Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.

Epilepsia. 2009 Dec;50(12):2629-37. doi: 10.1111/j.1528-1167.2009.02191.x. Epub 2009 Jul 2.

14.

Pathophysiologic characteristics of balloon cells in cortical dysplasia.

Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, Woo YJ, Kim JH, Kim HI, Kim SU.

Childs Nerv Syst. 2008 Feb;24(2):175-83. Epub 2007 Sep 26.

PMID:
17899129
15.

Altered distribution of KCC2 in cortical dysplasia in patients with intractable epilepsy.

Munakata M, Watanabe M, Otsuki T, Nakama H, Arima K, Itoh M, Nabekura J, Iinuma K, Tsuchiya S.

Epilepsia. 2007 Apr;48(4):837-44. Epub 2007 Feb 5.

16.

CD34-immunoreactive balloon cells in cortical malformations.

Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Bl├╝mcke I.

Acta Neuropathol. 2004 Oct;108(4):272-8. Epub 2004 Jun 19.

PMID:
15221338
17.

Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis.

Sarnat H, Flores-Sarnat L, Crino P, Hader W, Bello-Espinosa L.

Folia Neuropathol. 2012;50(4):330-45.

18.

Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat.

Irving EA, Bentley DL, Parsons AA.

Acta Neuropathol. 2001 Dec;102(6):627-35.

PMID:
11761724
19.

Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Shu HF, Yu SX, Zhang CQ, Liu SY, Wu KF, Zang ZL, Yang H, Zhou SW, Yin Q.

Brain Dev. 2013 Mar;35(3):252-60. doi: 10.1016/j.braindev.2012.04.007. Epub 2012 May 28.

PMID:
22647236
20.

Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly.

Salamon N, Andres M, Chute DJ, Nguyen ST, Chang JW, Huynh MN, Chandra PS, Andre VM, Cepeda C, Levine MS, Leite JP, Neder L, Vinters HV, Mathern GW.

Brain. 2006 Feb;129(Pt 2):352-65. Epub 2005 Nov 16.

PMID:
16291806

Supplemental Content

Support Center